A proven track record of value creation

Our robust business model provides significant opportunities to drive growth and deliver value for investors.

Together we’re building a leading global pharmaceutical business 

By putting better health within reach of patients every day through investment, innovation and diversification, we’re enhancing our portfolio responsibly and creating strong shareholder returns.

Explore our strategy

Latest stories

Decorative image.

Hikma delivers strong 2023 performance and a positive outlook for 2024

Press Release, Financial Results 22 February 2024